Free Trial

Leerink Partnrs Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leerink Partnrs. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leerink Partnrs.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
$18.19
-5.8%
5/21/2024Upgraded byLeerink PartnrsAnalyst T. SmithStrong-BuyLowView details for Leerink Partnrs rating of Q32 Bio (NASDAQ:QTTB) on 5/21/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$0.74
-2.6%
5/14/2024Downgraded byLeerink PartnrsAnalyst D. GrayboschStrong-Buy -> HoldLowView details for Leerink Partnrs rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 5/14/2024
Enhabit, Inc. stock logo
EHAB
Enhabit
$8.68
-1.8%
5/14/2024Upgraded byLeerink PartnrsAnalyst W. MayoStrong Sell -> HoldLowView details for Leerink Partnrs rating of Enhabit (NYSE:EHAB) on 5/14/2024
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$4.01
+0.5%
5/14/2024Downgraded byLeerink PartnrsAnalyst W. MayoStrong-Buy -> HoldLowView details for Leerink Partnrs rating of AirSculpt Technologies (NASDAQ:AIRS) on 5/14/2024
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
$2.68
-1.8%
5/10/2024Upgraded byLeerink PartnrsAnalyst R. RuizStrong-BuyLowView details for Leerink Partnrs rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/10/2024
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
$23.90
-0.5%
5/8/2024Upgraded byLeerink PartnrsAnalyst P. SoudaMarket Perform -> OutperformLowView details for Leerink Partnrs rating of Myriad Genetics (NASDAQ:MYGN) on 5/8/2024
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$106.71
+2.7%
5/6/2024Upgraded byLeerink PartnrsAnalyst A. BerensUnderperform -> Market PerformLowView details for Leerink Partnrs rating of Blueprint Medicines (NASDAQ:BPMC) on 5/6/2024
CVS Health Co. stock logo
CVS
CVS Health
$61.02
-0.1%
5/1/2024Downgraded byLeerink PartnrsAnalyst M. ChernyOutperform -> Market PerformLowView details for Leerink Partnrs rating of CVS Health (NYSE:CVS) on 5/1/2024
XOMA Co. stock logo
XOMA
XOMA
$22.31
-7.8%
4/29/2024Reiterated byLeerink PartnrsAnalyst D. RisingerOutperformLowView details for Leerink Partnrs rating of XOMA (NASDAQ:XOMA) on 4/29/2024
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
$1.75
+1.7%
4/30/2024Reiterated byLeerink PartnrsAnalyst R. RuizOutperformLowView details for Leerink Partnrs rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 4/30/2024
Immunocore Holdings plc stock logo
IMCR
Immunocore
$35.94
-2.8%
4/29/2024Reiterated byLeerink PartnrsAnalyst J. ChangOutperformLowView details for Leerink Partnrs rating of Immunocore (NASDAQ:IMCR) on 4/29/2024
Neurogene Inc. stock logo
NGNE
Neurogene
$30.32
-24.2%
4/29/2024Reiterated byLeerink PartnrsAnalyst M. ForooharOutperformLowView details for Leerink Partnrs rating of Neurogene (NASDAQ:NGNE) on 4/29/2024
Deciphera Pharmaceuticals, Inc. stock logo
DCPH
Deciphera Pharmaceuticals
$25.59
4/29/2024Downgraded byLeerink PartnrsAnalyst A. BerensOutperform -> Market PerformLowView details for Leerink Partnrs rating of Deciphera Pharmaceuticals (NASDAQ:DCPH) on 4/29/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$42.83
-0.4%
4/25/2024Upgraded byLeerink PartnrsAnalyst M. KratkyMarket Perform -> OutperformLowView details for Leerink Partnrs rating of Tandem Diabetes Care (NASDAQ:TNDM) on 4/25/2024
CureVac stock logo
CVAC
CureVac
$3.25
-6.6%
4/25/2024Downgraded byLeerink PartnrsAnalyst M. ForooharOutperform -> Market PerformLowView details for Leerink Partnrs rating of CureVac (NASDAQ:CVAC) on 4/25/2024
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$21.76
-6.7%
4/23/2024Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$22.89
-2.1%
4/16/2024Reiterated byLeerink PartnrsAnalyst D. RisingerOutperformLowView details for Leerink Partnrs rating of AnaptysBio (NASDAQ:ANAB) on 4/16/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$7.32
-2.1%
4/15/2024Reiterated byLeerink PartnrsAnalyst R. LiOutperformLowView details for Leerink Partnrs rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 4/15/2024
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
$18.32
-0.7%
4/15/2024Reiterated byLeerink PartnrsAnalyst M. GoodmanOutperformLowView details for Leerink Partnrs rating of LENZ Therapeutics (NASDAQ:LENZ) on 4/15/2024
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
$64.97
4/11/2024Downgraded byLeerink PartnrsAnalyst T. SmithOutperform -> Market PerformLowView details for Leerink Partnrs rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/11/2024
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$334.75
4/5/2024Downgraded byLeerink PartnrsAnalyst M. KratkyOutperform -> Market PerformLowView details for Leerink Partnrs rating of Shockwave Medical (NASDAQ:SWAV) on 4/5/2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
$5.95
-5.4%
4/5/2024Reiterated byLeerink PartnrsAnalyst R. RuizOutperformLowView details for Leerink Partnrs rating of Ardelyx (NASDAQ:ARDX) on 4/5/2024
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$7.87
-1.5%
4/3/2024Reiterated byLeerink PartnrsAnalyst J. ParkOutperformLowView details for Leerink Partnrs rating of Larimar Therapeutics (NASDAQ:LRMR) on 4/3/2024
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$78.10
+1.2%
4/1/2024Upgraded byLeerink PartnrsAnalyst A. BerensMarket Perform -> OutperformLowView details for Leerink Partnrs rating of Nuvalent (NASDAQ:NUVL) on 4/1/2024
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$3.95
-6.4%
3/25/2024Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/25/2024
Fusion Pharmaceuticals Inc. stock logo
FUSN
Fusion Pharmaceuticals
$21.55
3/19/2024Downgraded byLeerink PartnrsAnalyst F. KhurshidOutperform -> Market PerformLowView details for Leerink Partnrs rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/19/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
$2.48
+4.6%
3/18/2024Reiterated byLeerink PartnrsAnalyst J. SchwartzOutperformLowView details for Leerink Partnrs rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/18/2024
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$0.63
-3.1%
3/14/2024Downgraded byLeerink PartnrsAnalyst J. SchwartzOutperform -> Market PerformLowView details for Leerink Partnrs rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$1.62
-1.8%
3/11/2024Downgraded byLeerink PartnrsAnalyst M. GoodmanOutperform -> Market PerformLowView details for Leerink Partnrs rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 3/11/2024
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$12.21
+4.9%
3/6/2024Upgraded byLeerink PartnrsAnalyst M. ForooharMarket Perform -> OutperformLowView details for Leerink Partnrs rating of REGENXBIO (NASDAQ:RGNX) on 3/6/2024
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$8.08
-3.9%
3/5/2024Upgraded byLeerink PartnrsAnalyst R. RuizMarket Perform -> OutperformLowView details for Leerink Partnrs rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/5/2024
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
$7.44
-5.7%
3/4/2024Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of Kyverna Therapeutics (NASDAQ:KYTX) on 3/4/2024
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$37.27
-0.8%
2/23/2024Reiterated byLeerink PartnrsAnalyst A. BerensOutperformLowView details for Leerink Partnrs rating of IDEAYA Biosciences (NASDAQ:IDYA) on 2/23/2024
Doximity, Inc. stock logo
DOCS
Doximity
$27.56
-1.9%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Doximity (NASDAQ:DOCS) on 2/26/2024
Certara, Inc. stock logo
CERT
Certara
$13.37
-7.0%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Certara (NASDAQ:CERT) on 2/26/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$25.66
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 2/26/2024
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$7.03
-0.8%
2/22/2024Reiterated byLeerink PartnrsAnalyst A. BerensOutperformLowView details for Leerink Partnrs rating of Relay Therapeutics (NASDAQ:RLAY) on 2/22/2024
Progyny, Inc. stock logo
PGNY
Progyny
$25.73
-3.7%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of Progyny (NASDAQ:PGNY) on 2/26/2024
Envista Holdings Co. stock logo
NVST
Envista
$16.99
-1.3%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyUnderperformLowView details for Leerink Partnrs rating of Envista (NYSE:NVST) on 2/26/2024
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$78.10
+1.2%
2/22/2024Reiterated byLeerink PartnrsAnalyst A. BerensMarket PerformLowView details for Leerink Partnrs rating of Nuvalent (NASDAQ:NUVL) on 2/22/2024
This Weight Loss Company Can't Make Enough Product (Ad)

A tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!

Get the name of the company and their stock ticker here >>>
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$206.49
+2.4%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of Laboratory Co. of America (NYSE:LH) on 2/26/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$137.32
+0.2%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Quest Diagnostics (NYSE:DGX) on 2/26/2024
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$8.50
-3.4%
2/22/2024Reiterated byLeerink PartnrsAnalyst A. BerensOutperformLowView details for Leerink Partnrs rating of Cogent Biosciences (NASDAQ:COGT) on 2/22/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
$24.82
-0.5%
2/22/2024Reiterated byLeerink PartnrsAnalyst A. BerensOutperformLowView details for Leerink Partnrs rating of Arvinas (NASDAQ:ARVN) on 2/22/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
$242.20
-1.4%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Align Technology (NASDAQ:ALGN) on 2/26/2024
Accolade, Inc. stock logo
ACCD
Accolade
$6.15
-0.6%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of Accolade (NASDAQ:ACCD) on 2/26/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$16.11
+6.3%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Walgreens Boots Alliance (NASDAQ:WBA) on 2/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$10.10
-0.1%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Teladoc Health (NYSE:TDOC) on 2/26/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
$12.52
+0.3%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of R1 RCM (NASDAQ:RCM) on 2/26/2024
Premier, Inc. stock logo
PINC
Premier
$18.18
+0.4%
2/26/2024Reiterated byLeerink PartnrsAnalyst S. DavisMarket PerformLowView details for Leerink Partnrs rating of Premier (NASDAQ:PINC) on 2/26/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$25.38
+11.1%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of Patterson Companies (NASDAQ:PDCO) on 2/26/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$17.09
+0.6%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Owens & Minor (NYSE:OMI) on 2/26/2024
McKesson Co. stock logo
MCK
McKesson
$602.93
+0.9%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of McKesson (NYSE:MCK) on 2/26/2024
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$212.93
-0.2%
2/26/2024Reiterated byLeerink PartnrsAnalyst S. DavisOutperformLowView details for Leerink Partnrs rating of IQVIA (NYSE:IQV) on 2/26/2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$68.28
+3.2%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Henry Schein (NASDAQ:HSIC) on 2/26/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$24.76
+2.5%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyMarket PerformLowView details for Leerink Partnrs rating of Hims & Hers Health (NYSE:HIMS) on 2/26/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$8.16
-2.7%
2/26/2024Reiterated byLeerink PartnrsAnalyst S. DavisOutperformLowView details for Leerink Partnrs rating of GoodRx (NASDAQ:GDRX) on 2/26/2024
CVS Health Co. stock logo
CVS
CVS Health
$61.02
-0.1%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of CVS Health (NYSE:CVS) on 2/26/2024
Cencora, Inc. stock logo
COR
Cencora
$237.22
+1.1%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of Cencora (NYSE:COR) on 2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$104.09
+3.1%
2/26/2024Reiterated byLeerink PartnrsAnalyst M. ChernyOutperformLowView details for Leerink Partnrs rating of Cardinal Health (NYSE:CAH) on 2/26/2024
Applied Therapeutics, Inc. stock logo
APLT
Applied Therapeutics
$4.50
-6.8%
2/22/2024Reiterated byLeerink PartnrsAnalyst J. SchwartzOutperformLowView details for Leerink Partnrs rating of Applied Therapeutics (NASDAQ:APLT) on 2/22/2024
RAPT Therapeutics, Inc. stock logo
RAPT
RAPT Therapeutics
$3.19
-3.6%
2/21/2024Downgraded byLeerink PartnrsAnalyst T. SmithOutperform -> Market PerformLowView details for Leerink Partnrs rating of RAPT Therapeutics (NASDAQ:RAPT) on 2/21/2024
enGene Holdings Inc. stock logo
ENGN
enGene
$8.36
-3.4%
2/20/2024Reiterated byLeerink PartnrsAnalyst M. ForooharOutperformLowView details for Leerink Partnrs rating of enGene (NASDAQ:ENGN) on 2/20/2024
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$10.52
+1.2%
2/20/2024Reiterated byLeerink PartnrsAnalyst W. MayoOutperformLowView details for Leerink Partnrs rating of BrightSpring Health Services (NASDAQ:BTSG) on 2/20/2024
Synlogic, Inc. stock logo
SYBX
Synlogic
$1.59
2/9/2024Downgraded byLeerink PartnrsAnalyst J. SchwartzOutperform -> Market PerformLowView details for Leerink Partnrs rating of Synlogic (NASDAQ:SYBX) on 2/9/2024
Amgen Inc. stock logo
AMGN
Amgen
$305.99
+0.9%
2/7/2024Downgraded byLeerink PartnrsAnalyst D. RisingerOutperform -> Market PerformLowView details for Leerink Partnrs rating of Amgen (NASDAQ:AMGN) on 2/7/2024
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$306.04
+3.0%
2/5/2024Reiterated byLeerink PartnrsAnalyst R. RuizOutperformLowView details for Leerink Partnrs rating of United Therapeutics (NASDAQ:UTHR) on 2/5/2024
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$3.89
-4.7%
1/31/2024Upgraded byLeerink PartnrsAnalyst D. GrayboschMarket Perform -> OutperformLowView details for Leerink Partnrs rating of 2seventy bio (NASDAQ:TSVT) on 1/31/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$6.50
1/30/2024Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of NeuroPace (NASDAQ:NPCE) on 1/30/2024
Immunome, Inc. stock logo
IMNM
Immunome
$13.28
+1.0%
1/29/2024Reiterated byLeerink PartnrsAnalyst A. BerensOutperformLowView details for Leerink Partnrs rating of Immunome (NASDAQ:IMNM) on 1/29/2024
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$3.42
-6.6%
1/23/2024Reiterated byLeerink PartnrsAnalyst J. La. RosaOutperformLowView details for Leerink Partnrs rating of Pyxis Oncology (NASDAQ:PYXS) on 1/23/2024
agilon health, inc. stock logo
AGL
agilon health
$6.74
+1.4%
1/8/2024Downgraded byLeerink PartnrsAnalyst W. MayoOutperform -> Market PerformLowView details for Leerink Partnrs rating of agilon health (NYSE:AGL) on 1/8/2024
AlloVir, Inc. stock logo
ALVR
AlloVir
$0.74
+1.4%
12/22/2023Downgraded byLeerink PartnrsAnalyst M. ForooharOutperform -> Market PerformLowView details for Leerink Partnrs rating of AlloVir (NASDAQ:ALVR) on 12/22/2023
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$5.71
-4.7%
12/19/2023Upgraded byLeerink PartnrsAnalyst J. SchwartzMarket Perform -> OutperformLowView details for Leerink Partnrs rating of Wave Life Sciences (NASDAQ:WVE) on 12/19/2023
Nanobiotix S.A. stock logo
NBTX
Nanobiotix
$4.54
-6.0%
12/8/2023Reiterated byLeerink PartnrsAnalyst J. ChangOutperformLowView details for Leerink Partnrs rating of Nanobiotix (NASDAQ:NBTX) on 12/8/2023
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
$15.55
+3.4%
12/7/2023Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of Tourmaline Bio (NASDAQ:TRML) on 12/7/2023
MorphoSys AG stock logo
MOR
MorphoSys
$18.12
-1.0%
12/6/2023Reiterated byLeerink PartnrsAnalyst A. BerensMarket PerformLowView details for Leerink Partnrs rating of MorphoSys (NASDAQ:MOR) on 12/6/2023
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$3.16
-4.2%
11/30/2023Reiterated byLeerink PartnrsAnalyst M. ForooharOutperformLowView details for Leerink Partnrs rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/30/2023
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
$15.64
-3.8%
11/28/2023Reiterated byLeerink PartnrsAnalyst M. ForooharOutperformLowView details for Leerink Partnrs rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$13.55
11/14/2023Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 11/14/2023
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
$1.13
11/13/2023Downgraded byLeerink PartnrsAnalyst T. SmithOutperform -> Market PerformLowView details for Leerink Partnrs rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/13/2023
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
$4.14
-50.7%
11/7/2023Downgraded byLeerink PartnrsAnalyst A. BerensOutperform -> Market PerformLowView details for Leerink Partnrs rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/7/2023
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$3.89
-4.7%
10/30/2023Downgraded byLeerink PartnrsAnalyst D. GrayboschOutperform -> Market PerformLowView details for Leerink Partnrs rating of 2seventy bio (NASDAQ:TSVT) on 10/30/2023
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$23.17
-3.6%
10/20/2023Downgraded byLeerink PartnrsAnalyst M. ForooharOutperform -> Market PerformLowView details for Leerink Partnrs rating of Beam Therapeutics (NASDAQ:BEAM) on 10/20/2023
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
$25.50
-0.2%
10/17/2023Downgraded byLeerink PartnrsAnalyst P. SoudaOutperform -> Market PerformLowView details for Leerink Partnrs rating of Olink Holding AB (publ) (NASDAQ:OLK) on 10/17/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$22.78
-4.3%
10/18/2023Upgraded byLeerink PartnrsAnalyst M. ForooharMarket Perform -> OutperformLowView details for Leerink Partnrs rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/18/2023
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
$10.71
-4.4%
10/16/2023Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of Pliant Therapeutics (NASDAQ:PLRX) on 10/16/2023
Morphic Holding, Inc. stock logo
MORF
Morphic
$26.16
+0.2%
10/16/2023Reiterated byLeerink PartnrsAnalyst T. SmithOutperformLowView details for Leerink Partnrs rating of Morphic (NASDAQ:MORF) on 10/16/2023
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$31.20
-1.9%
10/16/2023Reiterated byLeerink PartnrsAnalyst T. SmithMarket PerformLowView details for Leerink Partnrs rating of Kymera Therapeutics (NASDAQ:KYMR) on 10/16/2023
Vericel Co. stock logo
VCEL
Vericel
$43.37
+4.0%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of Vericel (NASDAQ:VCEL) on 10/16/2023
This Weight Loss Company Can't Make Enough Product (Ad)

A tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!

Get the name of the company and their stock ticker here >>>
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$42.83
-0.4%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyMarket PerformLowView details for Leerink Partnrs rating of Tandem Diabetes Care (NASDAQ:TNDM) on 10/16/2023
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$334.75
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of Shockwave Medical (NASDAQ:SWAV) on 10/16/2023
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$62.00
-0.1%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of PROCEPT BioRobotics (NASDAQ:PRCT) on 10/16/2023
Insulet Co. stock logo
PODD
Insulet
$196.40
-1.0%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of Insulet (NASDAQ:PODD) on 10/16/2023
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$162.59
-0.7%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyMarket PerformLowView details for Leerink Partnrs rating of Inspire Medical Systems (NYSE:INSP) on 10/16/2023
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$88.53
+1.9%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyMarket PerformLowView details for Leerink Partnrs rating of Edwards Lifesciences (NYSE:EW) on 10/16/2023
DexCom, Inc. stock logo
DXCM
DexCom
$116.64
+0.1%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of DexCom (NASDAQ:DXCM) on 10/16/2023
Axonics, Inc. stock logo
AXNX
Axonics
$67.51
+0.3%
10/16/2023Reiterated byLeerink PartnrsAnalyst M. KratkyOutperformLowView details for Leerink Partnrs rating of Axonics (NASDAQ:AXNX) on 10/16/2023
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$63.15
-1.7%
10/11/2023Reiterated byLeerink PartnrsAnalyst D. GrayboschMarket PerformLowView details for Leerink Partnrs rating of Gilead Sciences (NASDAQ:GILD) on 10/11/2023
Amgen Inc. stock logo
AMGN
Amgen
$305.99
+0.9%
10/11/2023Upgraded byLeerink PartnrsAnalyst D. RisingerMarket Perform -> OutperformLowView details for Leerink Partnrs rating of Amgen (NASDAQ:AMGN) on 10/11/2023
Arcellx, Inc. stock logo
ACLX
Arcellx
$53.81
+0.1%
10/12/2023Reiterated byLeerink PartnrsAnalyst D. GrayboschOutperformLowView details for Leerink Partnrs rating of Arcellx (NASDAQ:ACLX) on 10/12/2023
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$8.08
-3.9%
9/21/2023Downgraded byLeerink PartnrsAnalyst R. RuizOutperform -> Market PerformLowView details for Leerink Partnrs rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 9/21/2023
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
$2.73
+1.1%
8/15/2023Reiterated byLeerink PartnrsAnalyst D. GrayboschMarket PerformLowView details for Leerink Partnrs rating of Turnstone Biologics (NASDAQ:TSBX) on 8/15/2023
Galecto, Inc. stock logo
GLTO
Galecto
$0.49
-2.0%
8/15/2023Downgraded byLeerink PartnrsAnalyst T. SmithOutperform -> Market PerformLowView details for Leerink Partnrs rating of Galecto (NASDAQ:GLTO) on 8/15/2023
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
$3.54
-7.3%
8/15/2023Downgraded byLeerink PartnrsAnalyst J. SchwartzOutperform -> Market PerformLowView details for Leerink Partnrs rating of Design Therapeutics (NASDAQ:DSGN) on 8/15/2023
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$51.94
-1.6%
8/15/2023Reiterated byLeerink PartnrsAnalyst R. RuizOutperformLowView details for Leerink Partnrs rating of Cytokinetics (NASDAQ:CYTK) on 8/15/2023
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$7.03
-0.8%
8/8/2023Reiterated byLeerink PartnrsAnalyst C. LiuOutperformLowView details for Leerink Partnrs rating of Relay Therapeutics (NASDAQ:RLAY) on 8/8/2023
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$78.10
+1.2%
8/8/2023Reiterated byLeerink PartnrsAnalyst C. LiuMarket PerformLowView details for Leerink Partnrs rating of Nuvalent (NASDAQ:NUVL) on 8/8/2023
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$37.27
-0.8%
8/8/2023Reiterated byLeerink PartnrsAnalyst C. LiuOutperformLowView details for Leerink Partnrs rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/8/2023
Exelixis, Inc. stock logo
EXEL
Exelixis
$21.56
-1.0%
8/8/2023Reiterated byLeerink PartnrsAnalyst C. LiuMarket PerformLowView details for Leerink Partnrs rating of Exelixis (NASDAQ:EXEL) on 8/8/2023
Quanterix Co. stock logo
QTRX
Quanterix
$13.78
-1.9%
8/8/2023Upgraded byLeerink PartnrsAnalyst P. SoudaMarket Perform -> OutperformLowView details for Leerink Partnrs rating of Quanterix (NASDAQ:QTRX) on 8/8/2023
NovoCure Limited stock logo
NVCR
NovoCure
$19.44
+0.2%
8/4/2023Reiterated byLeerink PartnrsAnalyst J. ChangOutperformLowView details for Leerink Partnrs rating of NovoCure (NASDAQ:NVCR) on 8/4/2023
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$5.71
-4.7%
8/4/2023Reiterated byLeerink PartnrsAnalyst J. SchwartzMarket PerformLowView details for Leerink Partnrs rating of Wave Life Sciences (NASDAQ:WVE) on 8/4/2023
Belite Bio, Inc stock logo
BLTE
Belite Bio
$49.65
+0.1%
7/26/2023Reiterated byLeerink PartnrsAnalyst M. GoodmanOutperformLowView details for Leerink Partnrs rating of Belite Bio (NASDAQ:BLTE) on 7/26/2023

MarketBeat Community Rating for Leerink Partnrs

Community Ranking:  2.5 out of 5 (
2.5 of 5 stars)
Outperform Votes:  5,837 (Vote Outperform)
Underperform Votes:  5,880 (Vote Underperform)
Total Votes:  11,717
MarketBeat's community ratings are surveys of what our community members think about Leerink Partnrs and other research firms. Vote "Outperform" if you believe Leerink Partnrs's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leerink Partnrs's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Forecasts and Research Tools